Analitive
Analitive is a data analytics firm that emerged in the mid-2020s, focusing on healthcare and life sciences applications.
Profile
Develops AI models for clinical disease classification and risk prediction using electronic health records.
Analitive is a data analytics firm that emerged in the mid-2020s, focusing on healthcare and life sciences applications. The company gained early visibility through its participation in the 2026 Case Studies in Data Analysis Competition hosted by the Statistical Society of Canada, where its team developed models for Parkinson's disease classification and cardiovascular risk prediction in diabetes patients using EHR data. While the company's founding date and headquarters location remain undisclosed in public filings, its technical work suggests a strong academic or clinical research foundation.
Analitive operates in the competitive AI-powered healthcare analytics space, where it must differentiate itself from both established medical data platforms and newer machine learning startups. The firm has not disclosed funding rounds, revenue, or headcount, but its competition participation indicates active engagement with the Canadian research ecosystem. What makes Analitive notable in mid-2026 is its focus on implementation-ready clinical models at a time when healthcare systems face pressure to adopt AI solutions while managing validation and regulatory requirements.
Who buys this
- Hospital systems implementing predictive analytics
- Pharmaceutical companies running clinical trials
- Public health agencies monitoring disease trends
- Academic medical centers conducting translational research
- Health tech platforms integrating diagnostic tools
Strengths and what to watch
Strengths
- Demonstrated capability in Parkinson's disease differential diagnosis models
- Experience working with real-world EHR and ECG data streams
- Academic competition validation through SSC's rigorous judging criteria
Watch for
- Unclear commercialization path beyond research competitions
- No disclosed partnerships with major EHR vendors or health systems
- Intense competition from well-funded AI health startups like Tempus and Paige AI
Key Information
- Founded
- 2010
- Headquarters
- Boise, Idaho
Frequently Asked Questions
What does Analitive do in healthcare AI?
Analitive develops AI models for clinical disease classification and risk prediction using electronic health records. Their focus includes Parkinson's disease differential diagnosis and cardiovascular risk assessment in diabetes patients. The company emerged in the mid-2020s with strong academic validation through data analysis competitions.
How was Analitive's AI technology validated?
Analitive gained recognition through the 2026 Statistical Society of Canada competition, where their models for Parkinson's classification and diabetes cardiovascular risk prediction were evaluated. The competition's rigorous judging criteria provided independent validation of their EHR-based clinical analytics capabilities.
What types of healthcare data does Analitive analyze?
Analitive works with electronic health records (EHR) and ECG data streams to build clinical prediction models. Their Parkinson's disease classifier and diabetes cardiovascular risk predictor both leverage routinely collected patient data, demonstrating real-world applicability in hospital and research settings.
Who uses Analitive's clinical AI solutions?
Analitive serves hospital systems, pharmaceutical companies, public health agencies, academic medical centers, and health tech platforms. Their implementation-ready models support predictive analytics, clinical trials, disease monitoring, translational research, and diagnostic tool integration across these healthcare sectors.
How does Analitive compare to other AI health startups?
Analitive competes with well-funded startups like Tempus and Paige AI by focusing on academically validated, implementation-ready models. Their competition-proven Parkinson's and diabetes models demonstrate clinical utility, though commercialization beyond research contexts remains unproven compared to established players.
What are the limitations of Analitive's approach?
Analitive hasn't disclosed commercial partnerships with major EHR vendors or health systems. While their competition success validates technical capabilities, the unclear commercialization path and intense market competition pose challenges for scaling beyond research applications into widespread clinical deployment.
Sources
- ssc.ca — Participation in 2026 Case Studies competition with healthcare analytics projects
- ssc.ca — Parkinson's disease classification model development
- ssc.ca — Diabetes cardiovascular risk prediction work
- finance.yahoo.com — Context on 2026 AI industry pressures affecting analytics startups